Evidence map›Paper›PMID 37306902›Full record

ArticleCancer treatment and research2023

Transforming Diagnosis and Therapeutics Using Cancer Genomics.

Sabba Mehmood, Shaista Aslam, Erum Dilshad, Hammad Ismail, Amna Naheed Khan

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer treatment and research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sabba MehmoodDepartment of Biological Sciences, National University of Medical Sciences (NUMS), Rawalpindi, Pakistan. sabba.mehmood@numspak.edu.pk.
Shaista AslamDepartment of Biological Sciences, National University of Medical Sciences (NUMS), Rawalpindi, Pakistan.
Erum DilshadDepartment of Bioinformatics and Biosciences, Faculty of Health and Life Sciences, Capital University of Science and Technology (CUST) Islamabad, Islamabad, Pakistan.
Hammad IsmailDepartments of Biochemistry and Biotechnology, University of Gujrat (UOG) Gujrat, Gujrat, Pakistan.
Amna Naheed KhanDepartment of Bioinformatics and Biosciences, Faculty of Health and Life Sciences, Capital University of Science and Technology (CUST) Islamabad, Islamabad, Pakistan.
Capital University of Science and Technology · PKNational University of Medical Sciences · PKUniversity of Gujrat · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In past quarter of the century, much has been understood about the genetic variation and abnormal genes that activate cancer in humans. All the cancers somehow possess alterations in the DNA sequence of cancer cell's genome. In present, we are heading toward the era where it is possible to obtain complete genome of the cancer cells for their better diagnosis, categorization and to explore treatment options.

Indexed as

NeoplasmsGenomicsHumansCancerGenomicsMicroarrayMultiomicsNGSSequencing

Identifiers

PMID37306902
OpenAlexW4380291900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.